October 11, Guronghui | eli lilly and co CEO said on Friday that the weight loss drug Zepbound is expected to be approved in Japan next year.
礼来CEO：减肥药Zepbound有望明年在日本获批
Eli Lilly and Co CEO: Weight loss drug Zepbound is expected to be approved in Japan next year.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated